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FIGURE 2. Computed tomography scan showing extension of embolus into the left atrium (A, arrow). Contrast-enhanced computed tomography scan
showing the emboli (arrows) in the distal left and right main pulmonary arteries (B).
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Maria Crespo, MD, Joseph Pilewski, MD, and Yoshiya Toyoda, MD, Pittsburgh, PaSince the first description of pulmonary alveolar microlithia-
sis (PAM) by Puhr1 in 1933, nearly 500 related cases have
been reported worldwide. No effective treatment for PAM
currently exists, with the exception of lung transplantation.
Herein, we present the case of a 63-year-old woman with
PAM who, to the best of our knowledge, is the oldest
successful lung transplant recipient with end-stage PAM
reported. In addition, the present work reviews the outcomes
of other cases of PAM after lung transplantation.From Cardiopulmonary Transplantation, University of Pittsburgh Medical Center,
Pittsburgh, Pa.
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A 63-year-old woman with PAM was initially referred to
our clinic for evaluation in 1998. The diagnosis was based
on results of an open lung biopsy performed 16 years ear-
lier, and the disease showed gradual progression, with 5
spontaneous instances of pneumothorax. The patient even-
tually became dependent on supplemental oxygen and
was markedly limited in activities of daily living (from
Fletcher Hugh-Jones criteria 4 to 5). She was deemed to
be a suitable candidate for lung transplantation on the basis
of our multidisciplinary transplant selection committee cri-
teria. At the time of listing, she had moderately restricted
pulmonary function with a forced vital capacity of 1.65 L
(50% of predicted), a forced expiratory volume in 1 second
of 1.49 L (62% of predicted), and a diffuse capacity for
carbon monoxide of 4.05 L $ min1 $ kPa1 (17% of pre-
dicted). Her 6-minute walk result was 830 feet on 5 L of
oxygen provided via a nasal cannula with desaturation to
79%. Cardiac catheterization showed a systolic pulmonary
artery pressure of 47 mm Hg, a transpulmonary gradient of
22 mm Hg, and mild coronary artery disease. A chest radio-
graph and computed tomographic scan on admission are
shown in Figure 1.ery c March 2010
FIGURE 1. Chest radiograph (A) and computed tomographic scan (B) on
admission.
FIGURE 2. Chest radiograph 1 year after double lung transplantation.
Brief Clinical ReportsIn July 2006, a donor became available for our patient.
The donor was a 52-year-old woman with a smoking history
of 30 packs per year and a height of 66 inches, whereas the
recipient was 67 inches in height. We performed double
lung transplantation without cardiopulmonary bypass, dur-
ing which severe adhesions were noted in the left side of
the chest and moderate adhesions in the right. The apexes
of the lungs were totally calcified and densely adherent to
the chest wall bilaterally, which led to difficulties in remov-
ing the native lungs, although we were eventually success-
ful. The allograft ischemic time was 256 minutes for the left
and 392 minutes for the right. Immunosuppressive therapy
consisted of intravenous alemtuzumab (Campath-1H) forThe Journal of Thoracic and Cainduction, with oral tacrolimus (Prograf), mycophenolate
mofetil (Cellcept), and prednisone given postoperatively.
The patient had an uneventful postoperative recovery. She
was extubated on postoperative day 1 and discharged
from the hospital 21 days after transplantation, without sup-
plemental oxygen. A chest radiograph 1 year after double
lung transplantation is shown in Figure 2. At present, 2
years after transplantation, the patient leads an independent,
active lifestyle and participates in normal activities of daily
living without dyspnea or the need for supplemental oxy-
gen. Her most recent pulmonary function test results
showed a forced vital capacity of 2.25 L (70% of predicted)
and a forced expiratory volume in 1 second of 1.84 L (81%
of predicted).COMMENT
We report a case of successful double lung transplanta-
tion in a 63-year-old patient with respiratory failure
caused by PAM, a rare disease in which microliths are
formed in alveolar air spaces.2 Although the disease pro-
gression is variable, the condition can remain static with
minor clinical manifestations, despite striking radiographic
features in affected individuals. Lung transplantation is
the only effective treatment for PAM and has been de-
scribed in several reports,3–6 which we have summarized
in Table 1.
The timing of transplantation remains controversial.
Edelman and associates5 suggested that it should be based
on the functional status of the patient, given the indolent
course of the disease. However, past reports related to
PAM also noted that patients with a long history of therdiovascular Surgery c Volume 139, Number 3 e51
TABLE 1. Summary of past reports related to PAM after lung transplantation
Pretransplant After 1 y
Author (y)
Patient
age (y) FVC (L) FEV1 (L) FVC (L) FEV1 (L)
Double or single
transplant CPB Complications Outcome
1. Bonnette (1992) 46 No data Double Off No Alive
2. Stamatis (1993) 32 2.3 1.8 3.6 2.7 Double On Major bleeding Alive, 18 mo
3. Edelman (1997) 56 1.11 0.99 Double On Major bleeding Dead on POD 5
4. Edelman (1997) 35 2.72 2.15 3.49 3.02 Double Off No Alive, 32 mo
5. Jackson (2001) 53 No data Single Off No Alive, 90 mo
6. Shigemura (2009) 63 1.65 1.49 2.25 1.84 Double Off No Alive, 16 mo
PAM, Pulmonary alveolar microlithiasis; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second; CPB, cardiopulmonary bypass.
Brief Clinical Reportsdisease tend to have severely advanced pleural involvement
characterized by dense pleural fibrosis and calcification with
increased vascularity.4,5 Furthermore, if the recipient has re-
current pneumothoraces treated, a pneumonectomy to re-
move the native lungs will be technically more difficult.
The 56-year-old patient in the report by Edelman and col-
leagues5 died on the fifth postoperative day of severe and
uncontrollable hemorrhage resulting from pleural involve-
ment of the native lungs. Therefore, when treating elderly
patients with end-stage PAM, the surgical team should be
prepared for such difficulties that may be encountered dur-
ing the operation. To avoid hemorrhagic complications, it
can be emphasized that double lung transplantation should
be completed without cardiopulmonary bypass. In both of
the cases complicated by major bleeding, including Edel-
man’s case, cardiopulmonary bypass was actually used, as
shown in Table 1. The present patient had severe adhesions
with calcification bilaterally; thus, we remained in close
contact with the donor procurement team and made arrange-
ments regarding aortic crossclamp time, which eventually
helped shorten the ischemic time. In addition, to proceed
without cardiopulmonary bypass, we transplanted the worst
lung first followed by the other based on the findings ofe52 The Journal of Thoracic and Cardiovascular Surgscintigraphy (ventilation/perfusion scan), which is of great
help to identify the worst side.
In summary, we successfully performed a double lung
transplantation in a case of respiratory failure resulting
from end-stage PAM. The patient is the oldest reported. Al-
though elderly recipients with end-stage PAM may have
technically difficult problems related to surgery, such trans-
plantation can be done safely and successfully when suffi-
cient strategies are used.
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